跳至主要内容
临床试验/ISRCTN37126758
ISRCTN37126758已完成未知

Pilot study to investigate the feasibility of 13-cis-retinoic acid pharmacokinetic monitoring in high-risk neuroblastoma patients

ewcastle upon Tyne Hospitals NHS Foundation Trust (UK)0 个研究点目标入组 103 人开始时间: 2010年6月18日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
103

研究概览

简要总结

2013 Results article in https://www.ncbi.nlm.nih.gov/pubmed/23087409 results (added 22/01/2019)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Age less than 18 years at time of registration, either sex
  • 2. Diagnosis of high-risk neuroblastoma
  • 3. Receiving 13-cis-retinoic acid (Roaccutane) as part of clinical treatment
  • 4. Single or double lumen central venous catheter in place
  • 5. Written informed consent
  • 6. Protocol approval by national and local ethics committee, regulatory authority and Trust R&D Departments
  • 7. A negative pregnancy test for women of childbearing potential, and sexually active patients and partners agreeing to undertake adequate contraceptive measures

排除标准

  • Failure to comply with any of the inclusion criteria

研究者

发起方
ewcastle upon Tyne Hospitals NHS Foundation Trust (UK)

相似试验